A randomized controlled pilot study to compare capecitabine-oxaliplatin with 5-FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectum

Abstract

In terms of ORR, pCR rate, R0 resection, and toxicity profile; both the arms were comparable.